FDA Approves Long-Acting Antifungal for Treating Candida

(MedPage Today) -- The FDA gave the greenlight to the long-acting antifungal rezafungin (Rezzayo), the first new treatment option for candidemia and invasive candidiasis to gain approval in over a decade, Cidara Therapeutics and Melinta Therapeutics...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news